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Studies of the Localization of the Intrarenal Renin-Angiotensin System epithelial cells situated in the distal convoluted tubule as it passes the glomerulus after it ascends from the medulla (Latta, 1973) . Collectively, the macula densa, the juxtaglomerular cells, and the afferent glomerular arteriole are termed the juxtaglomerular apparatus (Latta, 1973) (Fig. 1) .
Many investigators using micropuncture and microdissection techniques have shown that renal renin is released from the cells of the afferent arteriole, and that demonstrable renin activity is absent from other cells of the juxtaglomerular apparatus (Faarup, 1968; Faarup, 1971; Cook, 1971 ). Furthermore, immunological techniques in conjunction with flourescence microscopy have yielded a similar pattern of renin in the nephron (Warren et al., 1966; Hartroft et al., 1964) . Renin is secreted directly into the afferent arteriolar lumen (Horky et al., 1971 (Horky et al., , 1973 . A renal micropuncture study has shown that the concentration of renin in the efferent arteriole is lower than in the aorta (Morgan and Davis, 1975) . This observation suggests that renin also may be released into the interstitium and may enter the circulation at the capillary level. The concept that renin is released into the interstitium is supported to some extent by the finding that the renin concentration in renal lymph is approximately 10-fold higher than in renal venous blood (Lever and Peart, 1962; Hoise et al., 1970; Horky et al., 1971; Horky et al., 1973) , but this interpretation may be misleading because of differences in flow of lymph vs. arteriolar plasma. Theoretically, secretion of renin into the interstitium would allow enough time for renin substrate to be converted into angiotensin I and, subsequently, to angiotensin II. This mode of renin secretion would be consistent with a local action of the renin-angiotensin system within the kidney. If renin were released directly into the afferent arteriole, angiotensin formation might not occur rapidly enough to provide an intrarenal site of angiotensin action.
Interestingly, the renal tissue content of renin decreases from the superficial to the deep layers of the cortex, and it has been shown recently that 158 CIRCULATION RESEARCH VOL. 48, No. 2, FEBRUARY 1981 Sympathetic Neuron Afferent Arteriole Juxtaglomerular Cells Distal Tubule Glomerulus renin release is higher in the superficial than in the deep cortical and medullary nephrons (Peart, 1959; Brown et al., 1966; Jones et al., 1979) . This evidence suggests that angiotensin II may not be formed homogeneously throughout the kidney.
Localization of Converting Enzyme Activity within the Kidney
Angiotensin I does not have significant activity within the kidney, and converting enzyme is necessary to produce a biologically active peptide (DiSalvo et al., 1971) . Available evidence suggests that converting enzyme activity is present in the kidney, so that intrarenal formation of angiotensin II can occur (Granger et al., 1972) . Caldwell et al. (1976) labeled an antibody specific for rabbit pulmonary angiotensin-converting enzyme with fluorescein. In the kidney, staining was localized to the endothelial cells of renal arterioles and to glomerular and interglomerular capillaries. In these experiments, converting enzyme also was found on epithelial cells of the proximal tubule. Further studies by Ward et al. (1975) demonstrated that the enzyme was located in very high concentrations on the brush borders of these cells.
The presence of converting enzyme activity in the kidney also has been inferred indirectly from the reduction in renal blood flow produced by intrarenal infusion of angiotensin I. Assuming that the reduction in renal blood flow is due solely to the conversion of angiotensin I to II, several investigators have reported 7-19% conversion across the kidney (Franklin et al., 1970; Regoli and Cauthier, 1971) .
Formation of Angiotensin II within the Kidney
It has been suggested that converting enzyme activity also is present in renal lymph. The concen-tration of angiotensin II in renal lymph is far higher than in renal venous blood, suggesting that angiotensin II may be formed within the interstitial compartment (Baile et al., 1971) . This may explain the low rates of conversion of angiotensin I to II across the vascular space of the kidney. In addition, angiotensin II immunoreactive material, strongly resembling angiotensin II in many of its physiocochemical properties, is present in 10-to 20-fold higher concentrations in renal tissues than in aortic blood (Mendelsohn, 1976; Mendelsohn, 1979) . This material is not related to contamination by plasma angiotensin II, since the tissue concentration of angiotensin II exceeds that which can be accounted for by trapped blood (Mendelsohn, 1979) and is unaltered by perfusion of the renal vasculature (Mendelsohn, 1979) . This evidence strongly suggests that angiotensin II is formed locally within the kidney. Since converting enzyme activity is present in the interstitial and intravascular spaces along with renin substrate (Horkey et al., 1971; Horky et al., 1973) , the generation of angiotensin II from blood borne and/or intercellularly generated angiotensin I should occur. As discussed above, renin probably is released into the lumen of the afferent arteriole as well as into the interstitial space (Horkey et al., 1971; Horky, 1973; Morgan and Davis, 1975) . Angiotensin I could be generated in the afferent arteriole and pass into the glomerulus, either as angiotensin I or II, since converting enzyme activity is located on the endothelial surfaces of these vessels (Caldwell et al., 1976) . The locally generated octapeptide then could exert its effects on the afferent arteriole and in the glomerulus. Osborne et al. (1975) have demonstrated by autoradiography that 3 H-angiotensin II administered into the rat aorta in vivo localizes in the mesangial cells of the glomerulus. Also, Sraer et al. (1974) have produced evidence for specific binding sites for !25 I-angiotensin II in isolated rat glomeruli. These observations are consistent with a possible glomerular site of action of angiotensin II. Angiotensin II also may pass through the glomerulus, interact with the efferent arteriole, and pass into the peritubular capillaries where it might influence renal tubular function. Alternatively, angiotensin II could leak into the efferent arteriole from the interstitial space (Morgan and Davis, 1975) . The molecular weights of angiotensins I and II allow their filtration through the glomerular membrane and into the proximal tubule. The presence of converting enzyme activity on the brush border of the proximal tubular cells could catalyze the conversion of filtered angiotensin I to the octapeptide. Angiotensin II has been shown to bind to the brush borders of these cells and to induce a change in the ability of these cells to transport sodium (Steven, 1974; Harris and Young, 1977; Freedlender et al., 1977; Freedlender et al., 1979; Freedlender et al., 1980) . Theoretically, these anatomic-physiological relationships could allow intrarenally generated angiotensin II to alter renal function. However, since the half-life of plasma renin is 10-15 minutes, the kidney is exposed continuously to blood-borne angiotensins I and II generated extrarenally. The interrelationship and coordination of renal function between these routes of angiotensin generation are unknown at the present time.
Studies of the Functional Role of the Intrarenal Renin-Angiotensin System

Effects of Exogenous Angiotensin II on Renal Function
As discussed above, all of the components of the renin-angiotensin system are present within the kidney in close association with the component structures of the juxtaglomerular apparatus, and intrarenal formation of angiotensin II does occur (Granger et al., 1972; Thurau and Mason, 1974; Caldwell et al., 1976) . It is possible, therefore, that at least a portion of the renal sodium and water retention accompanying activation of the renin-angiotensin system might be due to a direct action of intrarenally produced angiotensin II on renal function as postulated by several investigators (Schmidt, 1962; Thurau, 1963; Guyton et al., 1964; Caldwell et al., 1976; Davis, 1977; Hall et al., 1977a; Ploth and Navar, 1979) . In support of the contention that angiotensin II can affect renal function, experiments have shown that intrarenal infusions of low subpressor doses of the hormone which do not alter peripheral circulating angiotensin II levels (Blair-West et al., 1971) consistently result in decreased renal blood flow and glomerular filtration rate (Bock et al., 1968; Navar and Langford, 1974) . The reduction in renal blood flow following angiotensin infusion is greater than the fall in glomerular filtration rate, leading to an increased filtration fraction (Navar and Langford, 1974) . This observation suggests that angiotensin II preferentially may constrict the efferent postglomerular arterioles. As a consequence of the reduction in glomerular filtration rate, there is a concurrent decrease in the excretion of water and electrolytes (Barraclough et al., 1967; Malvin and Vander, 1967; Johnson and Malvin, 1977) . This may be a direct consequence of lower renal blood flow, lower distal tubular delivery of sodium, or an effect of angiotensin II to increase sodium and water uptake across the renal tubules (Navar and Langford, 1974) .
In producing these changes in renal function, exogenously administered angiotensin II may act on all of the blood vessels and renal tubules in intimate contact with the renal blood supply. However, intrarenally produced angiotensin may not be formed in equal amounts throughout the kidney, and therefore, may not interact with all of the vessels and/or tubules stimulated by the exogenous peptide. Therefore, the renal effects of exogenous angiotensin may bear little or no relationship to those of the intrarenally formed peptide.
Effects of Intrarenal Administration of Blockers of the Renin-Angiotensin System on Renal Function
To counter this objection, the role of the intrarenal renin-angiotensin system has been investigated by inhibition of the formation of endogenous angiotensin II with converting enzyme inhibitors (teprotide and captopril) or by using peptide antagonists that inhibit the interaction of angiotensin with its tissue receptors. Clearly, inhibition of the expression of intrarenally formed angiotensin II should lead to profound changes in renal function if the endogenous peptide has important effects in the kidney. Early studies of renal arterial infusion of the angiotensin II receptor antagonist, saralasin, into animals after activation of the endogenous renin-angiotensin system by sodium depletion, renal artery occlusion, vena caval constriction or high output heart failure have demonstrated decreased renal vascular resistance with consequent large increases in renal blood flow (Freeman et al., 1975a; Mimran et al., 1974; Satoh and Zimmerman, 1975) . In most of these studies, no changes in glomerular filtration rate or electrolyte and water excretion were observed. These findings suggested that the intrarenal renin-angiotensin system plays an important role in regulating renal hemodynamics, but does not contribute to the regulation of water and electrolyte balance. In many of these early studies, the changes in renal function were associated with a reduction in mean arterial pressure. Although the increased renal blood flow in response to intrarenal inhibition of the renin-angiotensin system could not be due to the fall in blood pressure, reduced renal perfusion pressure could 160 CIRCULATION RESEARCH VOL. 48, No. 2, FEBRUARY 1981 have masked any changes in the excretion of sodium and water. Furthermore, other physiological systems may have been activated to control water and electrolyte excretion under the pathological conditions of caval constriction, high output heart failure, and renal artery stenosis, which may have obscured changes in renal function following inhibition of the renin-angiotensin system.
More recently, the role of the intrarenal reninangiotensin system in the control of renal function has been investigated in anesthetized and conscious dogs (Hall et al., 1977b; Trippodo et al., 1977) . These studies were performed after physiological activation of the renin-angiotensin system with dietary sodium restriction or water deprivation. In these experiments, intrarenal infusion of angiotensin receptor antagonists at doses that only slightly reduced arterial pressure resulted in increased renal blood flow, glomerular filtration rate, and sodium and water excretion. These data suggested that the intrarenal renin-angiotensin system could exert an action on renal sodium and water handling, as well as renal hemodynamics.
Since many angiotensin receptor antagonists are partial agonists and any such action would modulate the induced responses ascribed to receptor blockade, studies using the angiotensin-converting enzyme inhibitor, teprotide, were performed. Kimbrough et al. (1977) separately infused both saralasin and teprotide into the renal artery of sodiumdepleted conscious dogs at doses that did not change mean arterial pressure. Both compounds gave quantitative increases in glomerular filtration rate, renal blood flow, and sodium excretion, providing further evidence that the endogenous intrarenal renin-angiotensin system has the capability of influencing renal function. Changes in glomerular filtration rate, renal blood flow, and sodium excretion were not present in sodium-replete animals, indicating that activation of the renin-angiotensin system is an essential condition for the control of renal function by intrarenal angiotensin II. Kimbrough (1977) further demonstrated increased renal free water formation in reponse to intrarenal infusion of saralasin and teprotide, independent of changes in GFR and sodium balance. Precise interpretation of these observations was difficult, however, because the animals were studied in an uncontrolled state of water balance.
Primary Antidiuretic Action of Intrarenal Angiotensin II.
The effects of blockade of intrarenal angiotensin II formation with teprotide now have been studied under rigidly controlled conditions of hydropenia or water diuresis (Levens et al., in press, a) . After activation of the renin-angiotensin system by sodium depletion, intrarenal infusion of teprotide elicited consistent decreases in urinary osmolality and consistant increases in renal blood flow, glomerular filtration rate, urine volume, and free water formation. In these experiments, renal blood flow consistently increased to a greater degree than glomerular filtration rate, resulting in a decreased filtration fraction in response to angiotensin inhibition by teprotide. This observation supports the concept that angiotensin II preferentially constricts efferent arterioles. Glomerular filtration rate and circulating vasopressin are determinants of renal free water excretion (Wesson, 1969; Deetjen, 1975) . However, changes in angiotensin-dependent renal free water formation were dissociated from changes in glomerular filtration rate and circulating vasopressin. Further, intrarenal teprotide increased urine volume and free water formation under conditions of dehydration and administration of exogenous vasporessin to produce physiologically maximal circulating vasopressin. Under these circumstances, high baseline circulating vasopressin should have obscured any changes in endogenous vasopressin release which might have occurred from the pituitary. Therefore, the observed changes in renal free water formation almost certainly are due to a primary direct intrarenal antidiuretic action of angiotensin II. These results are consistent with investigations showing that intrarenal angiotensin II blockade delays recovery of urine osmolality after administration of furosemide (Imbs et al., 1978) . Studies from our laboratory using intrarenal infusion of saralasin have substantiated these results, thereby supporting the concept that inhibition of angiotensin II rather than potentiation of kinins is the primary cause of the observed results (Levens et al., 1979a) . Recent studies, demonstrating that low dose intravenous angiotensin II infusion reversed the effect of chronic captopril treatment on blood pressure and sodium excretion, have confirmed this impression (McCaa, 1979) .
Effects of Intrarenal Angiotensin II on Sodium Transport
Formation of a concentrated urine is brought about by the active transport of chloride and sodium out of the ascending limb of the loop of Henle to produce a hyperosmotic environment with respect to the fluid in the collecting ducts. On the basis of our findings, we advanced the hypothesis that angiotensin II stimulates sodium transport in the ascending limb of the loop of Henle. Inhibition of intrarenal angiotensin II formation with teprotide could decrease the medullary osmotic gradient and increase free water formation.
Some evidence exists in favor of the hypothesis that angiotensin II acts on sodium transport in this part of the kidney. Munday et al. (1971) used renal cortical slices and demonstrated that angiotensinstimulated salt and water transport is mediated by a ouabain-insensitive, potassium-independent sodium pump. This sodium pump is similar to that described by Wittembury and Proverbio (1970) in guinea pig renal cortical slices, which is inhibited specifically by ethacrynic acid, a diuretic that acts predominately on the active reabsorption of sodium and chloride from the ascending limb.
Angiotensin-induced changes in renal blood flow could account for the water and electrolyte changes in response to intrarenal angiotensin blockade. However this is unlikely, as Ploth and Navar (1979) , studying tubular sodium trasnsport by micropuncture following intrarenal inhibition of the reninangiotensin system in dogs, demonstrated that teprotide and saralasin depress tubular transport between the proximal and early distal tubule.
Reappraisal of the Intrarenal Renin-
Angiotensin System with Doses of Blockers which do not Influence the Systemic Renin-Angiotensin System.
In all of the previous studies of intrarenal angiotensin inhibition, changes in renal function as a consequence of infusion of angiotensin inhibitors into the kidney have been interpreted primarily as due to blockade of the intrarenal renin-angiotensin system. Clearly, the infused blockers could be leaking outside the kidney, stimulating or inhibiting production of other factors known to alter renal function. Under conditions of sodium depletion, intravenous infusion of teprotide or saralasin results in large reductions in mean arterial pressure. In many of the previously reported infusion studies, intrarenal infusion of the angiotensin inhibitors produced little if any change in arterial pressure. This has been taken as evidence that the blockers did not leave the kidney. However, intrarenal infusion of saralasin or teprotide produces rapid elevation of plasma renin activity and, hence, in systemic plasma angiotensin I and II concentrations (Bing and Poulsen, 1975) . Secretion of renin is achieved by removal of the negative feedback of angiotensin II on renin release. If intrarenal infusion of the inhibitors results in exclusive renal blockade, then one might expect an elevation of arterial blood pressure in the absence of peripheral blockade. In all of the previous experiments, arterial pressure remained the same or even decreased.
Based on the hypothesis that the angiotensin blockers might be leaving the kidney and inhibiting the peripheral as well as intrarenal renin-angiotensin systems, we induced systemic pressor responses with intravenous bolus injections of 3.2 jug of angiotensin I during simultaneous intrarenal infusions of differing doses of saralasin (Levens et al., 1979a) . We demonstrated that saralasin at doses higher than 0.07 itg/kg per min leaked from the kidney into the systemic circulation and attenuated angiotensin I-induced responses. In all of the studies reported previously, doses of 0.20-2.5 jug/kg per min have been used, suggesting that inhibition of the systemic renin-angiotensin system might have accounted for the observed changes in renal function.
We further demonstrated that the maximum dose allowable for specific renal blockade inhibited renal angiotensin II receptors, as it totally blocked the reduction in urine flow produced by the simultaneous intravenous infusion of 0.1 jig/min of angiotensin II. Intrarenal infusion of this low dose of saralasin reproducibly increased renal blood flow, glomerular filtration rate, and sodium, potassium and water excretion.
These experiments demonstrated that the intrarenal renin-angiotensin system exerts physiological effects on a variety of important renal functions and that caution should be exercised in the interpretation of studies in which inhibitors at doses greater than 0.07 /xg/kg per min are infused into the kidney and assumed to block only the intrarenal reninangiotensin system. Since angiotensin II may be formed in the renal interstitial compartment, the availability of the inhibitors to this compartment should be determined to facilitate interpretation of these studies.
Studies of the Intrarenal Vascular Effects of Angiotensin
Effects of Angiotensin II on the Function of the Afferent and Efferent Arterioles. The previous discussion focused on the observations that intrarenal infusion of angiotensin antagonists or converting enzyme inhibitors increases renal blood flow proportionately more than glomerular filtration rate with a consequent decrease in filtration fraction. This suggests that intrarenally formed angiotensin may control renal hemodynamics by preferential vasoconstriction of efferent arterioles. In support of this hypothesis, Krahe et al. (1970) and Davalos et al. (1978) demonstrtated that infusion of angiotensin II or renin substrate into the isolated perfused kidney reduces renal pulsatile flow but increases glomerular filtration rate and filtration fraction. Furthermore, the effects of renin substrate could be inhibited completely by depleting the kidneys of renin or adding teprotide or saralasin to the perfusion fluid, providing further evidence that intrarenally generated angiotensin II interacts at the level of the efferent arteriole. However, it is entirely possible in these experiments that angiotensin formation induces a selective redistribution of blood flow toward corticomedullary nephrons, which possess a higher filtration fraction than outer cortical nephrons.
In accord with this hypothesis are observations showing that angiotensin II decreases blood flow to the outer renal cortex (LaGrange and Schmidt, 1975) . However, the octapeptide exerts a variable effect on inner cortical flow, which appears to be related to the induction of renal prostaglandin synthesis. When prostaglandin synthesis is inhibited with indomethacin (Itskovitz and McGiff, 1974) , angiotensin also decreases inner cortical and med-162 CIRCULATION RESEARCH VOL. 48, No. 2, FEBRUARY 1981 ullary blood flow. Interestingly, infusion of angiotensin I into the isolated perfused kidney in the presence or absence of a converting enzyme inhibitor induces a selective decrease in the inner cortical and medullary fractions of renal blood flow without affecting outer cortical flow. Although it is possible that angiotensin I may determine the partitioning of blood flow intrarenally (Itskovitz and McGiff, 1974; Vane and McGiff, 1975) , the kidney contains large quantities of enzymes capable of converting angiotensin I to II. As none of these studies with angiotensin I included measurement of angiotensin II in the renal venous effluent, a direct action of intrarenally produced angiotensin I has not been established.
Although most of the evidence suggests that the intrarenal renin-angiotensin system controls renal hemodynamics predominantly through an action on postglomerular vessels, there is some conflicting evidence. For example, Ploth and Navar have shown with micropuncture and clearance techniques in anesthetized dogs that intrarenal infusion of teprotide increases renal blood flow Navar et al., 1979) . However, in these experiments, whole kidney and single nephron glomerular filtration rates and estimated glomerular pressure did not change significantly. Afferent arteriolar resistance decreased significantly, although there was no change in resistance of the efferent arteriole. These investigators infused teprotide into the kidney at a rate of 5 mg/hr. This is in excess of a dose of 0.2 /i.g/kg per min, which, as we have shown by measuring plasma converting enzyme activity in conscious dogs, accumulates outside the kidney within 10 minutes of initiation of intrarenal infusion. It should be pointed out that other investigators have obtained evidence for an afferent action of angiotensin (Navar and Langford, 1974) . However, the majority of these studies have used the infusion of the exogenous peptide, which may not mimic the actions of the endogenous hormone. Therefore, we believe on the basis of available evidence that intrarenally produced angiotensin II preferentially constricts the efferent arteriole.
Effects of Angiotensin II on the Glomerular Capillaries
In addition to acting on glomerular arterioles, angiotensin II also appears to have an action on glomerular capillaries. Intravenous infusion of subpressor doses of angiotensin II results in a reduction of the glomerular permeability coefficient (Blantz et al., 1976) . It is not known if this is a direct effect on the capillary cells or indirectly due to contraction of the mesangium. The mesangial cells supporting the capillary loops do contain contractile fibers. Furthermore, the major part of low doses of 12S Iangiotensin II injected into the renal artery of the rat localizes in the mesangium (Osborne et al., 1975) . Other investigators have shown that mesan-gial cells grown in culture contract in response to angiotensin (Ausiello et al., 1979) .
Mesangial cells link the glomerulus to the juxtaglomerular apparatus and also produce cytoplasmic processes that project into the lumen of the glomerular capillaries. It is, therefore, intriguing to speculate that the mesnangium may contract in response to both intrarenally and systemically formed angiotensin II. Contraction of the glomerular capillaries would reduce glomerular capillary hydraulic conductivity, and hence effective filtration pressure, leading to a decreased filtration fraction. Thus, intrarenally formed angiotensin may contribute to renal hemodynamics by an action on the efferent arteriole and the mesangial cells.
Intrarenal Role of Angiotensin III
Although it generally is accepted that angiotensin II is the main effector of the renin-angiotensin system, there is now considerable experimental evidence to suggest that other angiotensin peptides exhibit considerable activity in a number of sensitive tissues. Most studies in the kidney have concentrated on the effect of angiotensin II. Recently, however, Freeman et al. (1975) infused both angiotensins II and III ([des-Asp']-angiotensin II) into the renal artery of sodium-replete dogs and noted comparable reductions in renal blood flow and renin release in response to both compounds. In contrast, Taub et al. (1977) showed angiotensin II to have a greater effect on the renal vasculature than angiotensin III. Furthermore, in Taub's studies, crosstachyphylaxis between the peptides occurred, which led to the assumption that angiotensins II and III act in the kidney on a single receptor which has structural properties that differ from those of the systemic vascular angiotensin receptor. Taub et al. noted that the heptapeptide antagonist, [des-Asp'Jle^-angiotensin II, induced a greater increase in renal blood flow than saralasin after activation of the renin-angiotensin system by caval occlusion. This may suggest that angiotensin II is a primary agonist on the renal vasculature. Hall et al. (1979) have investigated the role of intrarenally produced angiotensin III by infusing the heptapeptide antagonist [des-Asp',Ile 8 ]-angiotensin II intrarenally in sodium-depleted dogs. Intrarenal infusion of the inhibitor did not alter any aspect of renal function. However, Freeman et al. (1975b) have shown that intrarenal infusion of angiotensin III results in a large decrease in plasma renin activity, suggesting that the heptapeptide, like angiotensin II, inhibits renal renin release. Hence, the renal effects of inhibition of angiotensin III may be masked by a concomitant increase in circulating systemic angiotensin II. Furthermore, Hall et al. (1979) failed to determine if the heptapeptide antagonist was leaking from the kidney to cause systemic accumulation. An effect of the inhibition of peripheral angiotensin III action may have masked any actions due to inhibition of the intrarenal heptapeptide.
Evidence for a Direct Tubular Action of
Angiotensin Experiments involving intrarenal infusion of angiotensin inhibitors indicate that the intrarenal reninangiotensin system can determine renal hemodynamics and electrolyte and water excretion. However, in these studies, only the net handling of sodium and water by the entire kidney can be measured. The inherent nature of these preparations does not allow for separation between (1) a direct action of the inhibitor to increase electrolyte excretion by inhibition of an angiotensin-stimulated tubular transport process, or (2) an indirect effect on glomerular filtration due to inhibition of angiotensin-induced vasoconstriction. An important component of the increased sodium and water excretion occurring during the infusion of the antagonists may be the concurrent increase in glomerular filtration rate and, hence, the filtered sodium load. However, recent evidence would suggest that part of the increased renal sodium excretion observed in these experiments may be due to inhibition of a direct action of angiotensin on renal tubular transport of sodium and water.
In Vivo Studies
Early studies on the kidney in vivo indirectly suggest a direct tubular effect of angiotensin II. For example, intravenous infusion of angiotensin II in dogs elevates the distal tubular concentrations of sodium, indicating that the peptide inhibits distal tubular sodium transport (Vander, 1963 ). An inhibitory action of the hormone on proximal as well as distal sodium transfer has been inferred from the delayed collapsed of the tubular lumen following angiotensin infusion after renal artery constriction (Leyssac, 1967) . However, these studies have not been confirmed by other investigators (Nagel et al., 1966) .
Micropuncture Studies
More recently, studies on the in situ kidney show that angiotensin exerts a dose-dependent dual action on sodium reabsorption across the renal tubules. A sodium diuresis occurs in rats after administration of high doses of angiotensin, whereas low infusion rates result in sodium retention (Harris and Young, 1977) . Barraclough et al. (1967) suggested that the effects of angiotensin were due to a direct action on a tubular transport process. Bonjour and Malvin (1969) concluded that the diuresis produced by high doses of angiotensin was due to inhibition of a tubular transport process, whereas the antidiuretic response to low doses of angiotensin was regarded as secondary to renal vasoconstriction and a reduced glomerular nitration rate. Micropuncture and microperfusion studies of single nephrons also have emphasized the variability of tubular sodium transport following intravenous administration of angiotensin. A major problem in these in vivo studies is the difficulty in separating the hemodynamic effects from the direct tubular effects of the hormone. Furthermore, systemic administration of angiotensin could result in diversion of cortical blood to the medulla and indirectly influence the tubular handling of sodium and water in the cortical nephrons studied in the micropuncture and microperfusion experiments. Published observations indicate variable changes in inner cortical and medullary blood flow in response to exogenous angiotensin II (LaGrange and Schmidt, 1975; Itskovitz and McGiff, 1974; Vane and McGiff, 1975) . However, the situation may be markedly different for angiotensin formed intrarenally, as the major fraction of the renin is released from the cells in the outer cortical nephrons (Peart, 1959; Brown et al., 1966; Jones et al., 1979) .
A recent development has been the use of freeflow micropuncture combined with perfusion of the peritubular capillaries with angiotensin. Steven (1974) used this technique and found that angiotensin II inhibited proximal sodium transport, whereas Harris and Young (1977) demonstrated that the octapaptide exerted a dose-dependent dual action on sodium transport (low doses stimulated whereas high doses inhibited absorption). Thus, variation in the response of the kidney to angiotensin may be due to differences in the relative doses of the hormone used in these experiments.
Although the aforementioned in vivo and micropuncture experiments are suggestive of a direct effect of angiotensin on sodium transport by the renal tubule, the evidence is speculative, as infused angiotensin may change the vascular permeability of the glomerular or peritubular capillaries leading to changes in interstitial fluid pressure and indirectly affect the renal handling of sodium and water. For this reason, the effect of angiotensin on renal slices and isolated tubules has been studied. This approach excludes any indirect action of angiotensin through release of other hormones such as vasopressin and aldosterone which can affect renal function.
Studies of Renal Slices and Isolated Tubule Preparations
Angiotensin II in low doses increases the rate of active sodium extrusion by rat renal cortical slices. This effect does not involve cyclic AMP and is blocked by inhibitors of the translation level of protein synthesis (Munday et al., 1972) . Recently, Freedlender and Goodfriend (1977) have shown that angiotensin II can bind to and influence sodium transport in isolated proximal renal tubules. In these studies, the tubules are sodium-loaded and then incubated with the octapaptide. Low doses of angiotensin II (1(T 12 to 10~9 M) are associated with increased sodium extrusion from the cells, suggest-164 CIRCULATION RESEARCH VOL. 48, No. 2, FEBRUARY 1981 ing that antiotensin II is directly stimulating sodium pump activity. In contrast, high doses of angiotensin II (1CT 9 to 10~f i M) were linked to decreased sodium extrusion, suggesting that at these doses the hormone was able to inhibit sodium pump activity. In a series of separate experiments, these authors demonstrated binding of biologically active 12 :'I-labeled angiotensin in the tubules. Scatchard analysis of the binding showed a high affinity site at doses that produced increased sodium extrusion and a low affinity site at doses that inhibited transport (Freedlender and Goodfriend, 1977) . Furthermore, autoradiographic studies by Freedlender et al. (1980) indicate that the high affinity angiotensin binding site is on the basolateral membrane of the tubular cell, whereas the low affinity site is associated with the brush border membrane. These observations have important physiological implications and suggest that blood-borne angiotensin II interacts with high affinity receptors on the basolateral membrane of the cell to mediate sodium absorption. The purpose and function of the low affinity sites mediating sodium extrusion and located on the brush border membrane are open to speculation.
Studies of Non-Renal Transporting Epithelia
Because of the nonphysiological nature of isolated tubules and renal cortical slices, several investigators have sought to determine the action of angiotensin on other transporting epithelia. Tissue such as frog skin and the mammalian intestine have structural and functional properties similar to those of the mammalian nephron (Dicker, 1970) and respond to angiotensin with uptake of sodium and water at low doses and inhibition of transport at high doses (Coviello, 1972; Bolton et al., 1975) . Recently we (Levens et al., 1979b (Levens et al., , 1980 have shown that the stimulation of intestinal sodium transport measured as water transport produced by angiotensin can be inhibited by treatment of the animals with phentolamine or reserpine. This suggests that in the intestine the stimulation of transport by low doses of angiotensin is mediated via release of norepinephrine from the sympathetic nerve endings in close proximity to the transporting epithelial cells.
We have demonstrated that inhibitors of angiotensin, although potent antagonists of the parent peptide in vascular tissue, are equipotent to or have even greater activity than the parent peptide in stimulating sodium and water uptake across the intestine in vivo (Levens et al., in press, b) . Further, Freedlender and Goodfriend (1977) have shown that 8-substituted analogs of angiotensin are potent full agonists of sodium transport by proximal tubular cells. In view of these observations, care should be exercised in the interpretation of data from experiments in which these analogs have been infused intrarenally. Clearly, they could inhibit the vascular effects of angiotensin, but act synergistically to stimulate tubular transport.
Role of Intrarenal Angiotensin in Renal Autoregulation
The unique anatomical structure of the juxtaglomerular apparatus and its intimate relationship to components of the renin-angiotensin system led Thurau to propose that intrarenally generated angiotensin II may participate in renal autoregulation. In essence, Thurau hypothesized that changes in the composition of the distal tubular fluid caused by increased renal perfusion pressure were sensed by the specialized cells of the macula densa, leading to renin release from adjacent juxtaglomerular cells (Thurau, 1964; Thurau et al., 1967) . Angiotensin II then is generated locally, leading to arteriolar vasoconstriction and a reduction in renal perfusion pressure.
Studies Supporting the Role of Angiotensin II in Renal Autoregulation
In support of this hypothesis, there is now a considerable amount of evidence to suggest that increased distal sodium and chloride transport in the macula densa results in renin release from juxtaglomerular cells (Shade et al., 1972; Tuck et al., 1974; Davis and Freeman, 1976) . However, the relationship of these observations to autoregulatory behavior as a result of changes in the intrarenal renin-angiotensin system is controversial. ), Brech et al., (1973 and Kaloyanides et al. (1977) all have reported that experimental manipulations resulting in decreased renin production by the kidney produce a loss of autoregulatory ability in isolated perfused dog kidneys. Intravenous administration of the converting enzyme inhibitor, teprotide, or of angiotensin analogs have been demonstrated to reduce the feedback response to elevated loop flow rate in the rat kidney (Stowe and Schnermann, 1974; Stowe et al., 1979) . In two-kidney, one-clip Goldblatt hypertensive rats, the contralateral undipped kidney fails to autoregulate, possibly secondary to marked renin depletion in the non-autoregulated kidney (Ploth et al., 1977) . Taken together, these observations suggest that intrarenally generated angiotensin may alter renal autoregulatory behavior. Hall et al. (1977a Hall et al. ( , 1977c demonstrated that blockade of the renin-angiotensin system following renin depletion or intrarenal infusion of an angiotensin II receptor antagonist results in attenuation of glomerular filtration rate but not of autoregulation of renal blood flow. These investigators, therefore, hypothesized that the resistance of both afferent and efferent arterioles diminishes as a result of decreased arterial pressure in the absence of the renin-angiotensin system. However, in the presence of an intact renin-angiotensin system, autoregulatory renal vasodilation results in large increases in renin release and angiotensin II production with consequent increased filtration by constriction of the efferent arteriole. Clearly, renin depletion also will affect angiotensin production systemically, whereas the inhibitor, which was infused at a dose of 0.25 ^tg/kg per min, leaks from the kidney and attenuates the activity of the systemic renin-angiotensin system.
Studies Failing to Support the Role of Angiotensin II in Renal Autoregulation
Interestingly, many investigators have failed to alter autoregulatory ability with intrarenal infusions of angiotensin antagonists during alterations in renal perfusion pressure (Anderson et al., 1975; Gagnon et al., 1974; Schmidt et al., 1973) . However, as plasma renin activity increases in response to intrarenal infusion of antagonists, it is possible that increased systemic angiotensin II production could mask any changes in renal autoregulatory behavior produced by inhibition of intrarenal angiotensin. In any experiments dealing with the problem of autoregulation, it is important to determine not only whether the infused blockers are leaving the kidney, but also the extent of intrarenal receptor blockade.
It is immediately obvious from the literature that the role of the intrarenal renin-angiotensin system in the autoregulation of renal hemodynamics is controversial. No studies to date involving micropuncture or whole animals have separated adequately inhibition of the function of the intrarenal from the peripheral renin-angiotensin system.
The Intrarenal Renin-Angiotensin System: Speculations on Its Role in Fluid and Electrolyte Homeostasis A considerable amount of evidence now suggests that angiotensin II generated locally within the kidney can influence renal function under conditions of sodium and water restriction. On the basis of this evidence, we would like to speculate on a hypothetical sequence of events involving the reninangiotensin system that leads to the profound changes in renal function following sodium restriction. After a small reduction in the distal sodium load to the macula densa, renin is released into both the afferent arteriole and the intercelluar compartment. As the renal tubules have a lower threshold for angiotensin than the renal vasculature, tubular transport is stimulated. If this fails to correct the decreased distal sodium load, more renin is released until the vascular threshold is reached. At this point, constriction of the efferent arteriole and glomerular mesangium results in diversion of blood flow to the inner cortex and medulla. This leads to decreased renal blood flow and glomerular filtration rate and further conservation of fluid volume.
Increasing sodium deprivation will produce greater renin release, causing the enzyme to escape the kidney and enter the systemic circulation. As a result of the peripheral generation of angiotensin II, aldosterone is secreted from the adrenal cortex and stimulates sodium uptake from the distal tubule. Further elevation of systemic angiotensin II con-centration will act to reinforce the intrarenal vasoconstrictor effects of intrarenally generated angiotensin, as well as stimulate the release of ADH from the pituitary.
In summary, we envisage the intrarenal reninangiotensin system as a mechanism to prevent renal sodium loss following mild sodium restriction. CIRCULATION RESEARCH VOL. 48, No. 2, FEBRUARY 1981 
